Cite

HARVARD Citation

    Schipani, S. et al. (n.d.). EP-1048: Phase I trial of a novel metalloporphyrin radiosensitiser (MTL005) in head and neck cancer. Radiotherapy and oncology. pp. S506-S507. [Online]. 
  
Back to record